The counter opened at Rs 3087.85 and touched an intraday high and low of Rs 3125.2 and Rs 3084.5, respectively, in the session so far. The stock of Torrent Pharmaceuticals Ltd. quoted a 52-week high of Rs 3248.0 and a 52-week low of Rs 2311.3.
As per BSE, the total market cap of the Torrent Pharmaceuticals Ltd. stood at Rs 52578.35 crore at the time of writing this report.
Key Financials
The company reported consolidated net sales of Rs 2174.0 crore for the quarter ended 30-Jun-2021, up 10.02 per cent from previous quarter’s Rs 1976.0 crore and up 5.53 per cent from the year-ago quarter’s Rs 2060.0 crore.
The net profit for latest quarter stood at Rs 330.0 crore, up 2.8 per cent from the corresponding quarter last year.
Shareholding pattern
As of 30-Jun-2021, DIIs held 6.66 per cent stake in the firm, while foreign institutional investors held 11.65 per cent and the promoters 71.25 per cent.
Valuation ratio
According to BSE data, the stock traded at a P/E multiple of 41.7 and a price-to-book ratio of 7.37. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Torrent Pharmaceuticals Ltd. belongs to the Pharma – Indian industry.
